Home
Healthcare
Diagnostics & Biotech
Synthetic Human Secretin Market Trends, Industry & Size 2030

Global Synthetic Human Secretin Market

Name: Growth Market Reports
Address: 500 East E Street, Ontario, 91764, USA
Telephone: +1 909 414 1393

Segments - By Types (Exocrine Pancreas Function Testing & Zollinger – Ellison Syndrome Testing), By end-user (Academics /Hospitals and clinics), and Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

HC-3996
4.2 Rating
180 Pages

22-11-21
80 Reviews

Author:

Raksha Sharma

Fact-checked by:

Vineet Pandey

Editor:

Shreyas Tandon

Report Description

Synthetic Human Secretin Market Outlook

The Global Synthetic Human Secretin Market was estimated at USD 8.4 million in 2020 and is anticipated to reach USD 12.7 million by 2028, expanding at a CAGR of 5.6% during the forecast period.

Synthetic secretin is a pure peptide hormone that has a similar amino acid sequence as naturally occurring secretin. It is also called a ChiRhoStim and human secretin. Synthetic secretin is intravenously administered. It is used for the diagnosis of pancreatic dysfunction or gastrinoma. Currently, synthetic secretin is used to diagnose prevalent pancreatic cancer disorders and chronic pancreatitis.

Scope of Synthetic Human Secretin Market Report

The report on the Global Synthetic Human Secretin Market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Synthetic Human Secretin Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast
Base Year	2020
Historic Data	2018–2019
Forecast Period	2021–2028
Segmentation	By Types (Exocrine Pancreas Function Testing & Zollinger – Ellison Syndrome Testing); By end-user (Academics /Hospitals and clinics)
Regional Scope	Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered	BCN Peptides; Bio-Techne; ChiRhoClin, Inc.; CPC Scientific Inc.; Hexonsynth; Prospec-Tany Technogene Ltd.; LifeTein LLC.; Abcam plc.; Abcepta; Creative BioMart; Merck KGaA; GenScript

Macro-economic Factors

R&D Activities

As many companies are testing their pancreatic diagnostic drug, which made a significant contribution to the development of products and technologies, which is expanding synthetic secretin research globally. Companies in this market are concentrating on technological advancements and research trends.

Coronavirus

Many pharmaceutical & biotechnology industries are being forced to close temporarily, lay off staff, or shift to remote operations. Many clinical trials were sharply halted during the pandemic. The implementation of lockdown limitations by government authorities had a negative impact on the manufacturing and operations in the healthcare industry. However, with the relaxation of regulations and the reopening of companies, the biopharmaceutical drug market is anticipated to grow steadily in the coming years.

Synthetic Human Secretin Market Dynamics

Market Driver- Increasing demand for diagnostic testing for pancreatic disorders

The primary testing is Pancreatic Function Test (PFT). This test checks for the reaction of the pancreas to a hormone (secretin) made by the small intestine. This test is in the US. For example, BCN Peptides S.A's synthetic human secretin is used in the diagnosis of pancreatic dysfunction, the presence of gastrinoma, and autism, which is expected to fuel market growth.

Market Driver- Growing Disposable Income across the globe

The demand for synthetic hormones is driven by rising disposable income across developing countries. For instance, the burden of chronic conditions is on the rise in India, demanding long-term support from healthcare services and governments organizations. Healthcare in India is primarily funded through out-of-pocket payments by households. It suggests improving the availability of reasonable diagnostics & medications for chronic disorders, as well as supporting primary care services. According to BEA, Disposable Personal Income (DPI) increased by $39.9 billion (0.2%) in 2022 worldwide.

Market Restraint- High R&D costs and a smaller number of players in the market

Very few players are present in the synthetic human secretin market, due to the approval procedure, and strict government policy. High expenditures are required for R&D activities for the clinical trials of the synthetic human secretin hormones for other pancreatic disorders. These factors are expected to hamper market growth.

Market Opportunity- Increasing technological advancements and pipelines of synthetic drugs

The number of synthetic hormone drugs is growing with the launch of innovative technology. In the presence, gastrointestinal endoscopy is used to develop a screening test for pancreatic cancer by using synthetic human secretin and a specially designed catheter, which is expected to lead to technological innovation in synthetic human secretin during the forecast period, which is projected to drive the market.

Synthetic Human Secretin Market Segmental Outlook

Based on types, the market is segmented into exocrine pancreas function testing and Zollinger – Ellison Syndrome Testing. The exocrine pancreas function testing segment held a significant share of the market. This test includes direct and indirect tests. Indirect tests are fueling the market, due to the availability of these tests in clinical settings.

Based on end-user, the market is fragmented into Academics /Hospitals and clinics. The Academics /Hospitals segment accounts for a substantial share of the market, during the forecast period, due to the innovation in diagnosis technology and growing number of hospitalization of patients with pancreatic diseases and cancer, and gastrointestinal disorders.

Synthetic Human Secretin Market Regional Outlook

Based on regions, the global synthetic human secretin market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The market in North America held a substantial share of the market, due to the increasing prevalence of pancreatitis, which affects around 80,000 people in the US each year. Two main types of pancreatitis are acute and chronic. About 90% of all cases that occur are acute pancreatitis, while 10% of the cases are chronic pancreatitis. Risk of pancreatic cancer is growing in patients with chronic pancreatitis, especially hereditary pancreatitis, owing to factors such as changing diet and lifestyle, smoking, and alcohol use, in this region. This is expected to boost the market in the future.

Europe accounts for a considerable share of the market, due to the growing prevalence of acute pancreatitis in Europe, and rising R&D investment in pancreatic cancer diagnostic tests. Safety regulations incorporated by governments in Germany and Italy and increasing incidence of pancreatic cancer in the countries are expected to propel the market.

Asia Pacific held a significant share of the market, as pancreatic cancer is prevalent in the region. Factors such as smoking, alcohol consumption, poor diet, and obesity are significant risk factors for pancreatic cancer. Incidence of pancreatic cancer, prevalence, and mortality rates are high in countries with high human development index (HDI) in Asia Pacific.

The Middle East & Africa held a considerable share of the market, owing to growing hospitalizations caused by acute pancreatitis & pancreatic cancer and advances in diagnosis & critical care management.

Key Benefits for Industry Participants & Stakeholders

In-depth Analysis of the Global Synthetic Human Secretin Market
Historical, Current, and Projected Market Size in terms of Value
Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
Industry Drivers, Restraints, and Opportunities Covered in the Study
Recent Industry Trends and Developments
Competitive Landscape & Strategies of Key Players
Neutral Perspective on Global Synthetic Human Secretin Market Performance

Segments

By Type

Academics /Hospitals
Clinics

By End-user

Exocrine Pancreas Function Testing
Zollinger – Ellison Syndrome Testing

By Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Key Players

BCN Peptides
Bio-Techne
ChiRhoClin, Inc.
CPC Scientific Inc.
Hexonsynth
Prospec-Tany Technogene Ltd.
LifeTein LLC.
Abcam plc.
Abcepta
Creative BioMart
Merck KGaA
GenScript

Competitive Landscape

Manufacturers operating in the Global Synthetic Human Secretin Market BCN Peptides; Bio-Techne; ChiRhoClin, Inc.; CPC Scientific Inc.; Hexonsynth; Prospec-Tany Technogene Ltd.; LifeTein LLC.; Abcam plc.; Abcepta; Creative BioMart; Merck KGaA; GenScript.
Market Players are pursuing key strategies such as acquisitions, collaborations, and geographic expansion where a potential opportunity arises for the global synthetic human secretin market.

Synthetic Human Secretin Market Key Players

Table Of Content

Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Synthetic Human Secretin Market Overview
   4.1 Introduction
      4.1.1 Market Taxonomy
      4.1.2 Market Definition
      4.1.3 Macro-Economic Factors Impacting the Market Growth
   4.2 Synthetic Human Secretin Market Dynamics
      4.2.1 Market Drivers
      4.2.2 Market Restraints
      4.2.3 Market Opportunity
   4.3 Synthetic Human Secretin Market - Supply Chain Analysis
      4.3.1 List of Key Suppliers
      4.3.2 List of Key Distributors
      4.3.3 List of Key Consumers
   4.4 Key Forces Shaping the Synthetic Human Secretin Market
      4.4.1 Bargaining Power of Suppliers
      4.4.2 Bargaining Power of Buyers
      4.4.3 Threat of Substitution
      4.4.4 Threat of New Entrants
      4.4.5 Competitive Rivalry
   4.5 Global Synthetic Human Secretin Market Size & Forecast, 2018-2028
      4.5.1 Synthetic Human Secretin Market Size and Y-o-Y Growth
      4.5.2 Synthetic Human Secretin Market Absolute $ Opportunity
   4.6 Pricing Analysis & Forecast, 2018-2028
   4.7 Global Synthetic Human Secretin Market: Impact Of Key Regulations
   4.8 Pipeline Analysis
Chapter 5 Global Synthetic Human Secretin Market Analysis and Forecast By Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities By Type
      5.1.2 Basis Point Share (BPS) Analysis By Type
      5.1.3 Absolute $ Opportunity Assessment By Type
   5.2 Synthetic Human Secretin Market Size Forecast By Type
      5.2.1 Exocrine Pancreas Function Testing
      5.2.2 Zollinger – Ellison Syndrome Testing
   5.3 Market Attractiveness Analysis By Type
Chapter 6 Global Synthetic Human Secretin Market Analysis and Forecast By End-user
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities By End-user
      6.1.2 Basis Point Share (BPS) Analysis By End-user
      6.1.3 Absolute $ Opportunity Assessment By End-user
   6.2 Synthetic Human Secretin Market Size Forecast By End-user
      6.2.1 Academics /Hospitals
      6.2.2 Clinics
   6.3 Market Attractiveness Analysis By End-user
Chapter 7 Global Synthetic Human Secretin Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Synthetic Human Secretin Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
   8.1 Introduction
   8.2 Current & Future Impact Analysis
   8.3 Economic Impact Analysis
   8.4 Government Policies
   8.5 Investment Scenario
Chapter 9 North America Synthetic Human Secretin Analysis and Forecast
   9.1 Introduction
   9.2 North America Synthetic Human Secretin Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Synthetic Human Secretin Market Size Forecast By Type
      9.6.1 Exocrine Pancreas Function Testing
      9.6.2 Zollinger – Ellison Syndrome Testing
   9.7 Basis Point Share (BPS) Analysis By Type
   9.8 Absolute $ Opportunity Assessment By Type
   9.9 Market Attractiveness Analysis By Type
   9.10 North America Synthetic Human Secretin Market Size Forecast By End-user
      9.10.1 Academics /Hospitals
      9.10.2 Clinics
   9.11 Basis Point Share (BPS) Analysis By End-user
   9.12 Absolute $ Opportunity Assessment By End-user
   9.13 Market Attractiveness Analysis By End-user
Chapter 10 Europe Synthetic Human Secretin Analysis and Forecast
   10.1 Introduction
   10.2 Europe Synthetic Human Secretin Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Synthetic Human Secretin Market Size Forecast By Type
      10.6.1 Exocrine Pancreas Function Testing
      10.6.2 Zollinger – Ellison Syndrome Testing
   10.7 Basis Point Share (BPS) Analysis By Type
   10.8 Absolute $ Opportunity Assessment By Type
   10.9 Market Attractiveness Analysis By Type
   10.10 Europe Synthetic Human Secretin Market Size Forecast By End-user
      10.10.1 Academics /Hospitals
      10.10.2 Clinics
   10.11 Basis Point Share (BPS) Analysis By End-user
   10.12 Absolute $ Opportunity Assessment By End-user
   10.13 Market Attractiveness Analysis By End-user
Chapter 11 Asia Pacific Synthetic Human Secretin Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Synthetic Human Secretin Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Synthetic Human Secretin Market Size Forecast By Type
      11.6.1 Exocrine Pancreas Function Testing
      11.6.2 Zollinger – Ellison Syndrome Testing
   11.7 Basis Point Share (BPS) Analysis By Type
   11.8 Absolute $ Opportunity Assessment By Type
   11.9 Market Attractiveness Analysis By Type
   11.10 Asia Pacific Synthetic Human Secretin Market Size Forecast By End-user
      11.10.1 Academics /Hospitals
      11.10.2 Clinics
   11.11 Basis Point Share (BPS) Analysis By End-user
   11.12 Absolute $ Opportunity Assessment By End-user
   11.13 Market Attractiveness Analysis By End-user
Chapter 12 Latin America Synthetic Human Secretin Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Synthetic Human Secretin Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Synthetic Human Secretin Market Size Forecast By Type
      12.6.1 Exocrine Pancreas Function Testing
      12.6.2 Zollinger – Ellison Syndrome Testing
   12.7 Basis Point Share (BPS) Analysis By Type
   12.8 Absolute $ Opportunity Assessment By Type
   12.9 Market Attractiveness Analysis By Type
   12.10 Latin America Synthetic Human Secretin Market Size Forecast By End-user
      12.10.1 Academics /Hospitals
      12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis By End-user
   12.12 Absolute $ Opportunity Assessment By End-user
   12.13 Market Attractiveness Analysis By End-user
Chapter 13 Middle East & Africa (MEA) Synthetic Human Secretin Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Synthetic Human Secretin Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Synthetic Human Secretin Market Size Forecast By Type
      13.6.1 Exocrine Pancreas Function Testing
      13.6.2 Zollinger – Ellison Syndrome Testing
   13.7 Basis Point Share (BPS) Analysis By Type
   13.8 Absolute $ Opportunity Assessment By Type
   13.9 Market Attractiveness Analysis By Type
   13.10 Middle East & Africa (MEA) Synthetic Human Secretin Market Size Forecast By End-user
      13.10.1 Academics /Hospitals
      13.10.2 Clinics
   13.11 Basis Point Share (BPS) Analysis By End-user
   13.12 Absolute $ Opportunity Assessment By End-user
   13.13 Market Attractiveness Analysis By End-user
Chapter 14 Competition Landscape
   14.1 Synthetic Human Secretin Market: Competitive Dashboard
   14.2 Global Synthetic Human Secretin Market: Market Share Analysis, 2020
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
      14.3.1 BCN Peptides
      14.3.2 Bio-Techne
      14.3.3 ChiRhoClin, Inc.
      14.3.4 CPC Scientific Inc.
      14.3.5 Hexonsynth
      14.3.6 Prospec-Tany Technogene Ltd.
      14.3.7 LifeTein LLC.
      14.3.8 Abcam plc
      14.3.9 Abcepta
      14.3.10 Creative BioMart
      14.3.11 Merck KGaA
      14.3.12 GenScript

Methodology

Purchase Premium Report

Buy Now

Request For Sample

Request For Customization

Enquiry Before Buying

Speak With Analyst

Customize This Report

Ask for Research To Be Focused On Specific Regions or Segments
Receive Data As Per Your Format and Definition
Companies Profiled based on Your Requirements
Breaking Down Competitive Landscape as per Your Requirements
Any Level of Customization

Our Clients

Client Testinomials

We needed a highly accurate and precise report, which Growth Market Reports delivered promptly. The company compiled information from a wide array of reliable agencies and sourcess.It is extremely satisfactory to be working with you.
Strategy Head of Major Tech Company

We were very pleased to contact Growth Market Reports as they tailored reports precisely as per our requirements. As we are dealing with the aerospace and defense industry, we need reports of high accuracy and substantial quality.
Major Player in Defense Industry

Extremely delighted to have a well-crafted report on “Global Packaging Solutions Market Research Report” from your team. Thank you for providing me with all our requirements and for incorporating our suggestions.
CMO of Leading Packaging Company from USA

I had a good experience working with Growth Market Reports as they were very open to all constructive changes in the report. I found that the report had its charm embedded with ample of data.
Founder and Managing Partner of Major Korean Company

Our company has been working with Growth Market Reports for some years now and we are very happy with the quality of the reports provided by the company.I, on behalf of my organization, would like to thank you for offering professional reports.
Global Consulting Firm

Quick Contact

+1 909 414 1393

sales@growthmarketreports.com

Growth Market Report

Certified By

FAQ Section

Some frequently asked quetions about this report!

1. Can I ask for different company profiles?

Additional company profiles can be provided on request

2. How big will be the Global Synthetic Human Secretin Market in 2028?

According to this Growth Market Reports report, the Global Synthetic Human Secretin Market is likely to register a CAGR of 5.6% during the forecast period 2020-2028, with a projected valuation of USD 12.7 million by the end of 2028.

3. What additional data analysis is available in a report?

In addition to market size (in US$ Million), Company Market Share (in % for the base year 2020), pricing analysis, the impact of key regulations, and pipeline analysis.

4. What are the criteria used for selecting a company profile?

Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.

5. What are the factors driving the growth of global synthetic human secretin market?

Rising diagnostic testing for pancreatic disorders, growing disposable income in emerging countries, and rising prevalence of pancreatic disorders are the factors anticipated to drive the market growth during the forecast period.

6. What is the impact of COVID-19 on the overall market during years 2019 -2020?

The Global synthetic human secretin market was slightly negatively impacted by the covid-19, owing to the disruptions in the form of supply chain breaks and shutdown of workspaces, caused by lockdowns imposed in various countries to control the spread of the disease.

7. What is the major type of Global Synthetic Human Secretin Market driving the market growth?

Exocrine pancreas function testing is the major type of global synthetic human secretin market.

8. Which is the base year calculated in the Global Synthetic Human Secretin Market report and what is the analysis period?

The base year considered for the Global Synthetic Human Secretin Market report is 2020. The complete analysis period is 2018 to 2028, wherein, 2018, and 2019 are the historic years, and the forecast is provided from 2021 to 2028.

9. Which macroeconomic factors affect the market?

Factors such as R&D activities, government regulations, the prevalence of pancreatic conditions, GDP, healthcare infrastructure, and demand are analyzed in the final report.